US Patent Issued to BeOne Medicines I on July 7 for "Aminopyrazine compounds as HPK1 inhibitor and the use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,933, issued on July 7, was assigned to BeOne Medicines I GmbH (Basel, Switzerland).

"Aminopyrazine compounds as HPK1 inhibitor and the use thereof" was invented by Jing Li (Beijing), Zhiwei Wang (Beijing), Sanjia Xu (Beijing), Hanzi Sun (Beijing) and Ye Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is an aminopyrazine compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein."

The patent was filed on Aug. 20, 2020, u...